Detalhe da pesquisa
1.
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus.
J Allergy Clin Immunol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670233
2.
Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locus.
J Allergy Clin Immunol
; 153(4): 1073-1082, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300190
3.
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial.
Lancet
; 401(10375): 458-469, 2023 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774155
4.
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10382): 1079-1090, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868261
5.
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 399(10328): 945-955, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219377
6.
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.
Allergy
; 77(7): 1961-1990, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35006617
7.
Consensus on treatment goals in hereditary angioedema: A global Delphi initiative.
J Allergy Clin Immunol
; 148(6): 1526-1532, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048855
8.
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
J Allergy Clin Immunol
; 148(1): 164-172.e9, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098856
9.
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
N Engl J Med
; 379(4): 352-362, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30044938
10.
Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema.
Allergy
; 75(5): 1165-1177, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815297
11.
Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries.
Pediatr Allergy Immunol
; 31(8): 974-989, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524650
12.
Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema.
Ann Allergy Asthma Immunol
; 125(3): 334-340.e1, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32445670
13.
A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema.
Pediatr Allergy Immunol
; 30(5): 553-561, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30968444
14.
[Hereditary angioedema]. / Hereditäres Angioödem.
Internist (Berl)
; 60(9): 987-995, 2019 Sep.
Artigo
em Alemão
| MEDLINE | ID: mdl-31363809
15.
Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings.
Int Arch Allergy Immunol
; 173(2): 114-119, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28662509
16.
Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence.
Allergy
; 75(8): 2115-2123, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32248571
17.
Burden of Illness in Hereditary Angioedema: A Conceptual Model.
Acta Derm Venereol
; 95(6): 706-10, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25394853
18.
Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study.
Transfusion
; 54(6): 1552-61, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24266596
19.
The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe.
Allergy Asthma Proc
; 35(1): 47-53, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24268449
20.
Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study.
J Allergy Clin Immunol Pract
; 12(1): 201-211.e6, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37730089